The specificity of the antiserum directed against Hyccin was determined by comparison of protein lysates from human healthy controls (n = 3) and HCC patient fibroblasts (n = 3) (mouse and human hyccin protein sequence are 97% homologous). The gene discussed is HYCC1; the disease is hepatocellular carcinoma.